AQUABOUNTY TECHNOLOGIES INC
For the period ended Sep 30, 2025. Filed Oct 28, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Oct 28, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 1. Financial Statements
Condensed Consolidated Balance Sheets
| As of | ||
|---|---|---|
| September 30, 2025 | December 31, 2024 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $951,434 | $230,362 |
| Prepaid expenses and other current assets | 519,027 | 292,018 |
| Current assets held for sale | 5,000 | 10,819,909 |
| Total current assets | 1,475,461 | 11,342,289 |
| Property, plant and equipment, net | 22,668,000 | 22,668,000 |
| Right of use assets, net | 30,330 | 51,509 |
| Total assets | $24,173,791 | $34,061,798 |
| Liabilities and stockholders' equity | ||
| Current liabilities: | ||
| Accounts payable and accrued liabilities | $3,069,766 | $10,104,853 |
| Accrued employee compensation | 914,067 | 977,088 |
| Current debt | 7,910,684 | 1,261,039 |
| Other current liabilities | 30,330 | 28,527 |
| Current liabilities held for sale | 8,741 | 3,830,041 |
| Total current liabilities | 11,933,588 | 16,201,548 |
| Long-term lease obligations | — | 22,982 |
| Long-term debt, net | — | 1,996,558 |
| Total liabilities | 11,933,588 | 18,221,088 |
| Commitments and contingencies (Note 11) | ||
| Stockholders' equity: | ||
| Common stock, $0.001 par value, 75,000,000 shares authorized; | ||
| 3,877,695 and 3,865,778 shares outstanding at September 30, 2025 and | ||
| December 31, 2024, respectively | 3,878 | 3,866 |
| Additional paid-in capital | 386,361,538 | 386,297,611 |
| Accumulated other comprehensive loss | — | (688,229) |
| Accumulated deficit | (374,125,213) | (369,772,538) |
| Total stockholders' equity | 12,240,203 | 15,840,710 |
| Total liabilities and stockholders' equity | $24,173,791 | $34,061,798 |
Condensed Consolidated Statements of Operations and Comprehensive Loss
| Three Months EndedSeptember 30, | Nine Months EndedSeptember 30, | |||
|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |
| Costs and expenses | ||||
| Sales and marketing | $— | $44,167 | 6,613 | 187,502 |
| Research and development | — | 70,300 | — | 220,916 |
| General and administrative | 1,412,112 | 1,501,811 | 4,741,144 | 7,029,547 |
| Asset impairment, net | 68,547 | — | 1,287,413 | 26,264,943 |
| Total costs and expenses | 1,480,659 | 1,616,278 | 6,035,170 | 33,702,908 |
| Operating loss | (1,480,659) | (1,616,278) | (6,035,170) | (33,702,908) |
| Other income (expense) | ||||
| Interest expense | — | (1,004,120) | (224,235) | (2,148,397) |
| Loan forgiveness | — | — | 2,008,046 | — |
| Other expense, net | (3,671) | (17,813) | (11,119) | (27,136) |
| Total other income (expense) | (3,671) | (1,021,933) | 1,772,692 | (2,175,533) |
| Loss from continuing operations | (1,484,330) | (2,638,211) | (4,262,478) | (35,878,441) |
| Income (loss) from discontinued operations | 103,557 | (766,120) | (90,197) | (29,198,379) |
| Net loss | $(1,380,773) | $(3,404,331) | $(4,352,675) | $(65,076,820) |
| Other comprehensive income (loss) | ||||
| Foreign currency translation gain (loss) | — | 65,701 | 688,229 | (107,941) |
| Comprehensive loss | $(1,380,773) | $(3,338,630) | $(3,664,446) | $(65,184,761) |
| Basic and diluted net (loss) income per share | ||||
| from continuing operations | $(0.38) | $(0.68) | $(1.10) | $(9.30) |
| from discontinued operations | 0.02 | (0.20) | (0.02) | (7.57) |
| Total basic and diluted net loss per share | $(0.36) | $(0.88) | $(1.12) | $(16.87) |
| Weighted average number of common shares | ||||
| - basic and diluted | 3,877,695 | 3,865,778 | 3,872,456 | 3,858,642 |
Condensed Consolidated Statements of Changes in Stockholders’ Equity
| Common stock issued and outstanding | Par value | Additional paid-in capital | Accumulated other comprehensive income (loss) | Accumulated deficit | Total | |
|---|---|---|---|---|---|---|
| Balance at December 31, 2023 | 3,847,022 | $3,847 | $385,998,213 | $(405,464) | $(220,579,878) | $165,016,718 |
| Net loss | (11,158,248) | (11,158,248) | ||||
| Other comprehensive loss | (116,307) | (116,307) | ||||
| Share-based compensation | 10,422 | 10 | 105,145 | 105,155 | ||
| Balance at March 31, 2024 | 3,857,444 | $3,857 | $386,103,358 | $(521,771) | $(231,738,126) | $153,847,318 |
| Net loss | (50,514,241) | (50,514,241) | ||||
| Other comprehensive loss | (57,335) | (57,335) | ||||
| Share-based compensation | 8,334 | 9 | 68,897 | 68,906 | ||
| Balance at June 30, 2024 | 3,865,778 | $3,866 | $386,172,255 | $(579,106) | $(282,252,367) | $103,344,648 |
| Net loss | (3,404,331) | (3,404,331) | ||||
| Other comprehensive income | 65,701 | 65,701 | ||||
| Share-based compensation | — | — | 65,632 | 65,632 | ||
| Balance at September 30, 2024 | 3,865,778 | $3,866 | $386,237,887 | $(513,405) | $(285,656,698) | $100,071,650 |
| Common stock issued and outstanding · Par value · Additional paid-in capital · Accumulated other comprehensive income (loss) · Accumulated deficit · Total | ||||||
|---|---|---|---|---|---|---|
| Balance at December 31, 2024 | 3,865,778 | $3,866 | $386,297,611 | $(688,229) | $(369,772,538) | $15,840,710 |
| Net income | 401,135 | 401,135 | ||||
| Other comprehensive income | 688,229 | 688,229 | ||||
| Share-based compensation | 3,583 | 3 | 40,158 | 40,161 | ||
| Balance at March 31, 2025 | 3,869,361 | $3,869 | $386,337,769 | $— | $(369,371,403) | $16,970,235 |
| Net loss | (3,373,037) | (3,373,037) | ||||
| Share-based compensation | 8,334 | 9 | 16,718 | 16,727 | ||
| Balance at June 30, 2025 | 3,877,695 | $3,878 | $386,354,487 | $— | $(372,744,440) | $13,613,925 |
| Net loss | (1,380,773) | (1,380,773) | ||||
| Share-based compensation | — | — | 7,051 | 7,051 | ||
| Balance at September 30, 2025 | 3,877,695 | $3,878 | $386,361,538 | $— | $(374,125,213) | $12,240,203 |
Condensed Consolidated Statements of Cash Flows
| Nine Months EndedSeptember 30, | ||
|---|---|---|
| 2025 | 2024 | |
| Operating activities | ||
| Net loss | $(4,352,675) | $(65,076,820) |
| Adjustment to reconcile net loss to net cash used in | ||
| operating activities: | ||
| Depreciation and amortization | — | 868,292 |
| Share-based compensation | 63,939 | 239,693 |
| Long-lived asset impairment | 1,287,413 | 48,733,222 |
| Loan forgiveness | (2,008,046) | — |
| Other non-cash items | (100,182) | 43,393 |
| Changes in operating assets and liabilities: | ||
| Inventory | — | 1,265,142 |
| Prepaid expenses and other assets | (344,671) | 1,041,947 |
| Accounts payable and accrued liabilities | (44,144) | 344,772 |
| Accrued employee compensation | (63,021) | (208,310) |
| Net cash used in operating activities | (5,561,387) | (12,748,669) |
| Investing activities | ||
| Purchases of and deposits on property, plant and equipment | — | (2,673,631) |
| Proceeds from asset sales | 7,105,884 | 9,511,625 |
| Net cash provided by investing activities | 7,105,884 | 6,837,994 |
| Financing activities | ||
| Proceeds from issuance of debt | — | 6,759,257 |
| Repayment of term debt | (832,194) | (9,547,358) |
| Net cash used in financing activities | (832,194) | (2,788,101) |
| Effect of exchange rate changes on cash and cash equivalents | 8,769 | (4,659) |
| Net change in cash and cash equivalents | 721,072 | (8,703,435) |
| Cash and cash equivalents at beginning of period | 230,362 | 9,203,869 |
| Cash and cash equivalents at end of period | $951,434 | $500,434 |
| Supplemental disclosure of cash flow information and non-cash transactions: | ||
| Interest paid in cash from continuing operations | $— | $2,111,160 |
| Interest paid in cash from discontinued operations | $16,903 | $81,091 |
| Non-cash conversion of accounts payable to current debt | $7,386,235 | $— |
| Property and equipment included in accounts payable and accrued liabilities | $2,565,881 | $9,473,373 |
Notes to the condensed consolidated financial statements
(unaudited)
- Nature of Business and Organization
AquaBounty Technologies, Inc. (the “Parent” and, together with its wholly owned subsidiaries, the “Company”) was incorporated in December 1991 in the State of Delaware for the purpose of conducting research and development of the commercial viability of a group of proteins commonly known as antifreeze proteins. In 1996, the Parent obtained the exclusive licensing rights for a gene construct (transgene) used to create a breed of farm-raised Atlantic salmon that exhibit growth rates that are substantially faster than conventional Atlantic salmon.
The Company has historically pursued a growth strategy that included the construction of large-scale recirculating aquaculture system (“RAS”) farms for producing its genetically engineered Atlantic salmon (“GE Atlantic salmon”). The Company had commenced construction of a 10,000 metric ton farm in Pioneer, Ohio (“Ohio Farm Project”), but paused the construction in June 2023, as the cost estimate to complete the farm continued to substantially increase due to inflation and other factors. Further, these cost increases impaired the Company’s ability to pursue municipal bond financing, which was a necessary component of its funding strategy. The Company subsequently engaged an investment bank to pursue a range of funding and strategic alternatives and to assist management in the prioritization of the Company’s core assets. These efforts resulted in the sale of the Company’s grow-out farm in Indiana (“Indiana Farm”) in July 2024, recurring sales throughout the remainder of 2024 and the first nine months of 2025 of selected equipment originally intended for the Ohio Farm Project (“Ohio Equipment Assets”), and the sale of the Company’s Canadian subsidiary, including the broodstock farms owned by the Canadian subsidiary in Prince Edward Island, Canada (“Canadian Farms”) and its intellectual property for GE Atlantic salmon, along with trademarks and patents (“Corporate IP”) in March 2025. After completion of these transactions, the Company’s primary remaining asset is its investment in the Ohio Farm Project, consisting of the remaining Ohio Equipment Assets and the land and construction in process (“Ohio Farm Site”). The Company continues to work with its investment bank to identify the optimal path forward for realizing the potential of this asset, either through new investment, partnership or other strategic options.
- Going Concern Uncertainty
Since inception, the Company has incurred cumulative net losses of $374 million and expects that this will continue for the foreseeable future. As of September 30, 2025, the Company had $951 thousand in cash and cash equivalents on its condensed consolidated balance sheet.
The Company’s ability to continue as a going concern is dependent upon its ability to raise additional capital, including its ability to sell assets to generate liquidity to fund ongoing operations, and there can be no assurance that such capital will be available in sufficient amounts, on a timely basis, or on terms acceptable to the Company, or at all. This raises substantial doubt about the Company’s ability to continue as a going concern within one year after the date that the accompanying condensed consolidated financial statements are issued. The accompanying condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business and do not include any adjustments that might result from the outcome of this uncertainty.
- Basis of Presentation
The unaudited interim condensed consolidated financial statements include the accounts of AquaBounty Technologies, Inc. and its wholly owned direct subsidiaries. All intercompany transactions and balances have been eliminated upon consolidation.
The unaudited interim condensed consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States (“GAAP”) consistent with those applied in, and should be read in conjunction with, the Company’s audited financial statements and related notes for the year ended December 31, 2024. The unaudited interim condensed consolidated financial statements reflect all adjustments, consisting only of normal recurring adjustments, which are, in the opinion of management, necessary for a fair presentation of the Company’s financial position as of September 30, 2025, results of operations and cash flows for the interim periods presented and are not necessarily indicative of results for subsequent interim periods or for the full year. The unaudited interim condensed consolidated financial statements do not include all of the information and notes required by GAAP for complete financial statements, as allowed by the relevant SEC rules and regulations; however, the Company believes that its disclosures are adequate to ensure that the information presented is not misleading.
Discontinued Operations
As noted above, the Company sold its Indiana Farm in July 2024 and its Canadian Farms in March 2025. These farms have been designated as discontinued operations in these interim condensed consolidated financial statements for all periods presented (see Note 5).
Net Loss Per Share
Basic and diluted net loss per share available to common stockholders has been calculated by dividing net loss by the weighted average number of shares of common stock outstanding during the period. Basic net loss per share is based solely on the number of shares of common stock outstanding during the period. The calculation of fully diluted net loss per share would include the number of shares of common stock issuable upon the exercise of vested options with an exercise price less than the fair value of the common stock and unvested stock awards, less the hypothetical number of shares of common stock that could be repurchased with stock option proceeds and unrecognized stock compensation. For all periods presented, all potential shares of common stock are considered anti-dilutive and are excluded from the calculation of diluted net loss per share.
The following table contains the Company’s potentially dilutive securities:
| Three Months Ended September 30, | ||
|---|---|---|
| Weighted Average Outstanding | 2025 | 2024 |
| Stock options | 45,894 | 72,375 |
| Unvested stock awards | - | 14,831 |
| Nine Months Ended September 30, | ||
|---|---|---|
| Weighted Average Outstanding | 2025 | 2024 |
| Stock options | 51,198 | 73,590 |
| Unvested stock awards | 5,330 | 22,206 |
Accounting Pronouncements
In November 2024, the Financial Accounting Standards Board issued Accounting Standards Update (“ASU”) No. 2024-03, Disaggregation of Income Statement Expenses, to enhance the transparency of certain expense disclosures. The update requires disclosure of specific expense categories in the notes to the financial statements at interim and annual reporting periods. The update requires disaggregated information about certain prescribed expense categories underlying any relevant income statement expense caption. The amendments in this update are effective for public entities for annual periods beginning after December 15, 2026, and interim periods beginning after December 15, 2027. The amendments may be adopted either prospectively or retrospectively. Early adoption is permitted. The Company is currently evaluating the impacts of this update and plans to adopt these amendments for annual disclosures for the year ended December 31, 2027, and interim disclosures in the year ended December 31, 2028.
Management does not expect any other recently issued, but not yet effective, accounting standards to have a material effect on its results of operations or financial condition.
- Risks and Uncertainties
The Company is subject to risks and uncertainties associated with its current operations. Such risks and uncertainties include, but are not limited to: (i) timing of securing additional sources of cash; (ii) realization of asset values different than those recorded on the Company’s consolidated balance sheet; and (iii) stockholder approval of any plans made by the Company’s management and board of directors that require stockholder approval.
Concentration of Credit Risk
Financial instruments that potentially subject the Company to credit risk consist principally of cash and cash equivalents. This risk is mitigated by the Company’s policy of maintaining all balances with highly rated financial institutions and investing in cash equivalents with maturities of less than 90 days. The Company’s cash balances may at times exceed insurance limitations.
- Discontinued Operations and Assets Held for Sale
In July 2024, the Company sold its Indiana Farm for a sale price of $9.5 million less transaction expenses of $305 thousand, which included certain Ohio Equipment Assets with a carrying value of $13.0 million that had been purchased for the Company’s Ohio Farm Project. In December 2024, the Company announced the winddown of its Canadian fish rearing operations and sold its Canadian Farms in March 2025 for a sale price of $5.2 million, including the assumption of $3.2 million in outstanding loans, less transaction expenses of $216 thousand. These decisions by the Company represented a strategic shift that has had a major effect on the Company’s operations and financial results. As a result, the operations of the Indiana Farm and the Canadian Farms have been reclassified as discontinued operations on a retrospective basis for all periods presented. Accordingly, the assets and liabilities of these operations are separately reported as “assets and liabilities held for sale” as of September 30, 2025 and December 31, 2024.
Included in the table for Current Assets Held for Sale is $5 thousand for September 30, 2025 and $6.3 million for December 31, 2024 of the Ohio Equipment Assets. During the nine months ended September 30, 2025, the Company sold certain Ohio Equipment Assets for gross proceeds of $5.0 million. The remaining Ohio Equipment Assets were determined to have a fair value of $5 thousand at September 30, 2025, and a cumulative non-cash impairment charge of $1.3 million has been recorded in continuing operations for the nine month period.
The table below presents the major areas of the balance sheet that constitute assets and liabilities held for sale.
| September 30, | December 31, | |
|---|---|---|
| 2025 | 2024 | |
| Current Assets | ||
| Prepaid and other current assets | $— | $65,030 |
| Property, plant and equipment, net | 5,000 | 10,754,879 |
| Total current assets held for sale | $5,000 | $10,819,909 |
| Current Liabilities | ||
| Accounts payable and accrued expenses | $— | $106,590 |
| Accrued employee compensation | — | 54,583 |
| Current debt | — | 3,260,005 |
| Other current liabilities | 8,741 | 408,863 |
| Total current liabilities held for sale | $8,741 | $3,830,041 |
The two tables below present the major areas of the income statement and the cash flow statement, respectively, that constitute discontinued operations.
| Three months ended September 30, | Nine months ended September 30, | |||
|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |
| Revenue | $— | $47,812 | $— | $705,262 |
| Costs and expenses | ||||
| Product costs | — | 425,057 | — | 6,542,437 |
| Sales and marketing | — | — | — | 330 |
| Research and development | — | (18,207) | — | 15,468 |
| General and administrative | (103,557) | 386,003 | 72,929 | 805,384 |
| Long-lived impairment | — | — | — | 22,468,279 |
| Operating income (loss) | 103,557 | (745,041) | (72,929) | (29,126,636) |
| Other expense | — | (21,079) | (17,268) | (71,743) |
| Income (loss) from discontinued ops | $103,557 | $(766,120) | $(90,197) | $(29,198,379) |
| Nine months ended September 30, | ||
|---|---|---|
| 2025 | 2024 | |
| Adjustments to reconcile net loss to net cash used in operating activities | ||
| Depreciation and amortization | $— | $855,998 |
| Long-lived asset impairment | — | 22,468,279 |
| Other non-cash items | (100,182) | 3,518 |
| Changes in working capital | (100,811) | 1,400,135 |
| Cash flows from investing activities | ||
| Purchases of and deposits on property, plant and equipment | — | (249,178) |
| Cash flows from financing activities | ||
| Proceeds from issuance of debt | — | 259,257 |
| Repayment of term debt | (32,194) | (155,595) |
- Prepaid and Other Current Assets
Major classifications of prepaid and other current assets are summarized as follows:
| September 30, 2025 | December 31, 2024 | |
|---|---|---|
| Receivables | $2,453 | $— |
| Prepaid insurance | 376,515 | 203,999 |
| Prepaid other | 140,059 | 88,019 |
| Total prepaid expenses and other current assets | $519,027 | $292,018 |
- Property, Plant and Equipment
Major classifications of property, plant and equipment are summarized as follows:
| September 30, 2025 | December 31, 2024 | |
|---|---|---|
| Land | $641,345 | $641,345 |
| Construction in process | 22,026,655 | 22,026,655 |
| Total property and equipment | $22,668,000 | $22,668,000 |
| Less accumulated depreciation and amortization | — | — |
| Property, plant and equipment, net | $22,668,000 | $22,668,000 |
Depreciation expense was $0 and $857 thousand, for the nine months ended September 30, 2025 and 2024, respectively.
The Company’s decision in 2024 to sell certain Ohio Equipment Assets, the Indiana Farm and the Canadian Farms to provide additional liquidity indicated the carrying amount of all Ohio Farm Project property, plant and equipment may not be recoverable. The Company compared future anticipated undiscounted cash flows for the different Ohio Farm Project asset groups to the carrying value of such asset groups, noting that the carrying value of these assets exceeded the cash flows. Therefore, the Company proceeded to calculate the fair values of these different asset groups, representing a Level 3 fair value measurement. The Company recorded non-cash impairment charges of $101.9 million against continuing operations during 2024, in addition to reclassifying $6.3 million of Ohio Equipment Assets to Assets Held for Sale as of December 31, 2024.
As of September 30, 2025, construction in process related only to the Ohio Farm Site.
- Debt
| Interestrate | Monthlyrepayment | Maturitydate | September 30, 2025 | December 31, 2024 | |
|---|---|---|---|---|---|
| ACOA AIF Grant | 0% | Royalties | $— | $1,996,558 | |
| Term Note | 0% | 200,000 | Dec 2025 | 524,449 | 1,261,039 |
| Vendor Note | 8% | — | Jun 2026 | 7,386,235 | — |
| Total debt | $7,910,684 | $3,257,597 | |||
| less: current portion | (7,910,684) | (1,261,039) | |||
| Long-term debt, net | $— | $1,996,558 | |||
On February 14, 2025, the Atlantic Canada Opportunities Agency (“ACOA”) terminated the outstanding loan with the Company’s Canadian subsidiary under its Atlantic Innovation Fund (“AIF”) Grant in the amount of C$2.9 million ($2.0 million). The AIF Grant was awarded in 2009 and provided a contribution towards the funding of a research and development project. Repayment was to be based on royalties from the resulting products from the research, however no product from the research was commercialized.
In October 2024, the Company entered into a secured promissory note (“Term Note”) for $1.3 million with a vendor for services provided during 2024. The Term Note is secured by the assets of the Company’s Ohio Farm Project and is due in full on December 31, 2025, withtwo intermediate scheduled payments. On March 18, 2025, an amendment to the Term Note was executed to alter the amount and timing of the intermediate payments. The Term Note carriesno interest, except in the event of a default, in which case any amount due for payment will be assessed accrued interest at 3% per annum. On July 22, 2025, the Term Note was again amended to alter the timing of the remaining payments and at September 30, 2025, the Company is in compliance with the terms of the loan as amended.
On June 11, 2025, the Company converted $7.4 million of outstanding accounts payable with a vendor into a secured promissory note (“Vendor Note”). The Vendor Note is secured by the assets of the Company’s Ohio Farm Site, has a 12-month term and carries an 8% interest rate, with thefirst six-months interest free.
The Company recognized interest expense of $0 and $1.8 million for the nine months ended September 30, 2025 and 2024, respectively, on its interest-bearing debt.
Principal payments due on the debt are as follows:
| Total | |
|---|---|
| 2025 remaining | $524,449 |
| 2026 | 7,386,235 |
| 2027 | — |
| 2028 | — |
| 2029 | — |
| Thereafter | — |
| Total | $7,910,684 |
- Leases
The tables below summarize the Company’s outstanding lease liabilities at September 30, 2025 and December 31, 2024 and its lease expense for the nine months ended September 30, 2025 and 2024:
| September 30, | December 31, | |
|---|---|---|
| 2025 | 2024 | |
| Operating lease right-of-use assets, net | $30,330 | $51,509 |
| Other current liabilities | 30,330 | 28,527 |
| Long-term lease obligations | - | 22,982 |
| Total operating lease liabilities | $30,330 | $51,509 |
| Weighted average remaining lease term | 1.0 years | 1.8 years |
| Weighted average discount rate | 8% | 8% |
| Remaining payments under leases: | |
|---|---|
| Year | Amount |
| 2025 remaining | $8,185 |
| 2026 | 21,826 |
| Thereafter | — |
| Total lease payments | 30,011 |
| Less: imputed interest | 319 |
| Total operational lease liabilities | $30,330 |
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |
| Operating lease expense | $7,870 | $8,803 | $23,611 | $32,679 |
| Lease payments included in operating cash flows | $7,870 | $8,803 | $23,611 | $32,679 |
- Stockholders’ Equity
Share-based compensation
At September 30, 2025, the Company has reserved 44,706 and 0 shares of common stock issuable upon the exercise of outstanding stock options and unvested stock awards, respectively, under its 2006 and 2016 Equity Incentive Plans. An additional 101,917 shares of common stock are reserved for future equity awards under the 2016 Equity Incentive Plan.
Unvested Stock Awards
A summary of the Company’s unvested stock awards for the nine months ended September 30, 2025, is as follows:
| Shares | Weightedaverage grantdate fair value | |
|---|---|---|
| Unvested at December 31, 2024 | 12,567 | $9.18 |
| Vested | (11,917) | 8.96 |
| Forfeited | (650) | 13.05 |
| Unvested at September 30, 2025 | — | $— |
During the nine months ended September 30, 2025 and 2024, the Company expensed $33 thousand and $106 thousand, respectively, related to the stock awards.
Stock options
The Company’s option activity is summarized as follows:
| Number of options | Weightedaverageexercise price | |
|---|---|---|
| Outstanding at December 31, 2024 | 64,905 | $38.57 |
| Forfeited | (19,125) | 31.69 |
| Expired | (1,074) | 49.37 |
| Outstanding at September 30, 2025 | 44,706 | $41.25 |
| Exercisable at September 30, 2025 | 41,601 | $43.79 |
Unless otherwise indicated, options issued to employees, members of the Board of Directors, and non-employees generally vest over a period ofone year tothree years and are exercisable for a term of 10 years from the date of issuance. There wereno stock options granted during the nine months ended September 30, 2025.
There wasno intrinsic value for options outstanding or exercisable at September 30, 2025 and December 31, 2024.
The following table summarizes information about options outstanding and exercisable at September 30, 2025:
| Weightedaverage exerciseprice of outstandingoptions | Number ofoptionsoutstanding | Weightedaverage remainingestimated life(in years) | Number ofoptionsexercisable |
|---|---|---|---|
| < $10.00 | 16,517 | 7.7 | 13,412 |
| $20.00 - $50.00 | 24,998 | 4.2 | 24,998 |
| $100.00 - $200.00 | 1,516 | 5.1 | 1,516 |
| $200.00 - $300.00 | 1,675 | 1.6 | 1,675 |
| 44,706 | 41,601 |
Total share-based compensation on stock-option grants amounted to $30 thousand and $134 thousand for the nine months ended September 30, 2025 and 2024, respectively. At September 30, 2025, the balance of unearned share-based compensation to be expensed in future periods related to unvested share-based awards was $12 thousand. The period over which the unearned share-based compensation is expected to be earned is approximately 0.5 years.
- Commitments and Contingencies
The Company recognizes and discloses commitments when it enters into executed contractual obligations with other parties. The Company accrues contingent liabilities when it is probable that future expenditures will be made and such expenditures can be reasonably estimated.
The Company is subject to legal proceedings and claims arising in the normal course of business. Management believes that final disposition of any such matters existing at September 30, 2025, will not have a material adverse effect on the Company’s financial position or results of operations.
On June 25, 2025, a complaint was filed by Buckeye Power Sales Co. Inc. (“Buckeye”) against AquaBounty Farms Ohio LLC (“AFO”) in the Court of Common Pleas, Franklin County, Ohio. The complaint alleged that AFO ordered a switch gear from Buckeye in 2024 and entered into a credit contract with Buckeye. Buckeye claimed that AFO owed Buckeye $930 thousand plus interest at the rate of 1.5% per month from January 22, 2025, and costs, including attorney fees. On August 27, 2025, AFO and Buckeye executed a settlement and release agreement (“Settlement”) to resolve all matters and disputes between them. As part of the Settlement, AFO agreed to pay Buckeye $550 thousand and Buckeye agreed to release and discharge all claims against AFO and to dismiss the legal action it filed. The Company recorded a $550 thousand general and administrative expense during the nine months ended September 30, 2025 for the Settlement.
- Segment Reporting
The Company adopted ASU 2023-07 effective for the annual period beginning January 1, 2024.
The financial information presented to and reviewed by the Company’s chief operating decision maker, who is the interim chief executive officer, chief financial officer and treasurer, is not prepared in accordance with GAAP, therefore certain accounting policies
of the Company’ssingle operating and reportable segment differ significantly from those described in the Company’s 2024 Annual Report on Form 10-K, which was filed on March 27, 2025. The significant difference between how management prepares financial information for internal purposes and GAAP is that internal information is focused on overall cash expenditures.
Management monitors the financial results for internal purposes under a cash expenditure approach rather than GAAP, because management believes such results more closely align to how the business is currently managed with consideration of the Company’s overall focus on liquidity.
Management has identified net cash expenditures as the key performance measure that is used for evaluating the business. The chief operating decision maker uses this measure on a monthly basis when assessing performance and when making decisions about how to allocate operating resources, such as payments to vendors.
The Company believes that net cash expenditures, which is a non-GAAP measure, is the most directly comparable measure to GAAP. As such, the required disclosures of reportable segment expenses and segment loss in the tables below are prepared in accordance with the financial information presented to management and reviewed by the Company’s chief operating decision maker on a regular basis.
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| $ thousands | 2025 | 2024 | 2025 | 2024 |
| Corporate | $1,941 | $1,641 | $4,512 | $6,600 |
| Indiana farm | 103 | 171 | 187 | 3,262 |
| Ohio farm | 317 | 818 | 902 | 2,820 |
| Canadian operations | — | 977 | 272 | 3,332 |
| Net cash expenditures | $2,361 | $3,607 | $5,873 | $16,015 |
| Reconciliation of net cash expenditures | ||||
| to consolidated net loss: | ||||
| Depreciation and amortization | — | 146 | — | 868 |
| Share-based compensation | 7 | 66 | 64 | 240 |
| Long-lived asset impairment | 69 | - | 1,287 | 48,733 |
| Loan forgiveness and other non-cash items | (100) | — | (2,108) | — |
| Capitalized expenditures | — | (674) | — | (2,674) |
| Net realizable value adjustments | — | - | — | 1,093 |
| Working capital changes | (956) | 259 | (763) | 802 |
| Consolidated net loss: | $1,381 | $3,404 | $4,353 | $65,077 |
- Income Taxes
The Company reported a net loss for the nine months ended September 30, 2025, and is forecasting losses through the remainder of the year, resulting in an estimated net loss for both financial statement and tax purposes for the year ending December 31, 2025. Therefore, no federal or state income taxes are expected andnone have been recorded at this time. Income taxes have been accounted for using the liability method.
Due to the Company’s history of losses since inception, there is not enough evidence at this time to support that the Company will generate future income of a sufficient amount and nature to utilize the benefits of its net deferred tax assets. Accordingly, the deferred tax assets have been reduced by a full valuation allowance, since the Company does not currently believe that realization of its deferred tax assets is more likely than not.
As of September 30, 2025, the Company hadno unrecognized income tax benefits that would reduce the Company’s effective tax rate if recognized.
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.